Cite
MLA Citation
Y Yazici et al.. “SAT0175 A descriptive analysis of real-world treatment patterns in a turkish rheumatology population that continued innovator infliximab (REMICADE) therapy or switched to biosimilar infliximab.” Annals of the rheumatic diseases, vol. 76, n.d., p. 836. http://access.bl.uk/ark:/81055/vdc_100135163686.0x000060